Reuters logo
3 years ago
Diasorin confirms 2014 guidance after Q1 core earnings fall
May 9, 2014 / 12:10 PM / 3 years ago

Diasorin confirms 2014 guidance after Q1 core earnings fall

MILAN, May 9 (Reuters) - Italian medical diagnostics group Diasorin confirmed its full-year guidance on Friday after posting a 7.2 percent fall in core earnings in the first quarter.

In a statement the company said earnings before interest, tax, depreciation and amortisation were 38.6 million euros ($53.5 million), dragged down by exchange rate fluctuations and costs to support its molecular business.

In 2014 Diasorin sees growth in core earnings of around 3 percent from last year's 163.1 million euros, at constant exchange rates. Revenues should grow by 3-5 percent this year compared to 2013. ($1 = 0.7214 Euros) (Reporting by Stephen Jewkes, editing by Danilo Masoni)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below